Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects
NORML
FEBRUARY 25, 2020
Investigators affiliated with the Saint Anthony Hospital and Medical Campus in Colorado assessed the impact of the off-label use of dronabinol (FDA-approved synthetic oral THC) on opioid consumption patterns in trauma patients with acute pain. Sixty-six patients participated in the study.
Let's personalize your content